Literature DB >> 9817123

Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.

N K Aaronson1, M Muller, P D Cohen, M L Essink-Bot, M Fekkes, R Sanderman, M A Sprangers, A te Velde, E Verrips.   

Abstract

The primary objectives of this research were to translate, validate, and generate normative data on the SF-36 Health Survey for use among Dutch-speaking residents of the Netherlands. Translation of the SF-36 into Dutch followed the stepwise, iterative procedures developed by the IQOLA Project. Following extensive pilot testing, the SF-36 was administered to: (1) a random sample of adult residents of Amsterdam (n = 4172); (2) a random, nationwide sample of adults (n = 1742); (3) a sample of migraine sufferers (n = 423); and (4) a sample of cancer patients undergoing active anti-neoplastic treatment (n = 485). Data quality across the four studies was consistently high. The rates of missing data ranged from 1% to 5% at the item level, and from 1.2% to 2.6% at the scale level. Multitrait scaling analysis confirmed the hypothesized scale structure of the SF-36 and associated scale scoring in all four samples. Cronbach's alpha coefficients surpassed the 0.70 criterion for group comparisons in all but one case (the Social Functioning scale in the cancer sample), with a mean alpha coefficient across all scales and samples of 0.84. Known-group comparisons yielded consistent support for the validity of the SF-36. In the two community samples, statistically significant differences in SF-36 mean scale scores were observed as a function of age, gender, and the prevalence of chronic health conditions. In the migraine and cancer samples, mean SF-36 scale scores varied significantly as a function of various indicators of disease severity. The SF-36 profiles for the two community samples were highly similar. The cancer sample yielded the lowest SF-36 scores, with the migraine sample holding an intermediate position. On-going studies will generate data on the responsiveness of the SF-36 to within-group changes in health over time. Efforts are underway to translate and validate the questionnaire for use among ethnic minority groups in the Netherlands.

Entities:  

Mesh:

Year:  1998        PMID: 9817123     DOI: 10.1016/s0895-4356(98)00097-3

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  586 in total

1.  The Canadian SF-36 health survey: normative data add to its value.

Authors:  S Wood-Dauphinee
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

2.  Neighbourhood socioeconomic context and self reported health and smoking: a secondary analysis of data on seven cities.

Authors:  S A Reijneveld
Journal:  J Epidemiol Community Health       Date:  2002-12       Impact factor: 3.710

3.  Treatment of chronic phantom limb pain using a trauma-focused psychological approach.

Authors:  Carlijn de Roos; A C Veenstra; A de Jongh; M den Hollander-Gijsman; N J A van der Wee; F G Zitman; Y R van Rood
Journal:  Pain Res Manag       Date:  2010 Mar-Apr       Impact factor: 3.037

4.  Validation of the KDQOL-SF: a dialysis-targeted health measure.

Authors:  J C Korevaar; M P Merkus; M A M Jansen; F W Dekker; E W Boeschoten; R T Krediet
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

5.  Need for recovery from work related fatigue and its role in the development and prediction of subjective health complaints.

Authors:  J K Sluiter; E M de Croon; T F Meijman; M H W Frings-Dresen
Journal:  Occup Environ Med       Date:  2003-06       Impact factor: 4.402

6.  Unidimensionality and reliability under Mokken scaling of the Dutch language version of the SF-36.

Authors:  P G M van der Heijden; S van Buuren; M Fekkes; J Radder; E Verrips
Journal:  Qual Life Res       Date:  2003-03       Impact factor: 4.147

7.  Development of the chronic fatigue syndrome in severely fatigued employees: predictors of outcome in the Maastricht cohort study.

Authors:  Marcus J H Huibers; I Jmert Kant; J André Knottnerus; Gijs Bleijenberg; Gerard M H Swaen; Stanislav V Kasl
Journal:  J Epidemiol Community Health       Date:  2004-10       Impact factor: 3.710

8.  An innovative care model coordinated by a physical therapist and nurse practitioner for osteoarthritis of the hip and knee in specialist care: a prospective study.

Authors:  Veronique M A Voorn; Henricus M Vermeulen; Rob G H H Nelissen; Margreet Kloppenburg; Tom W J Huizinga; Nicolette A C Leijerzapf; Herman M Kroon; Thea P M Vliet Vlieland; Henrica M J van der Linden
Journal:  Rheumatol Int       Date:  2013-01-17       Impact factor: 2.631

9.  Treatment of osteochondral defects of the talus in children.

Authors:  M L Reilingh; G M M J Kerkhoffs; C J A Telkamp; P A A Struijs; C N van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-09-18       Impact factor: 4.342

10.  Effectiveness of bed rest after mild traumatic brain injury: a randomised trial of no versus six days of bed rest.

Authors:  J R de Kruijk; P Leffers; S Meerhoff; J Rutten; A Twijnstra
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.